Icosavax Stock Current Ratio
Icosavax fundamentals help investors to digest information that contributes to Icosavax's financial success or failures. It also enables traders to predict the movement of Icosavax Stock. The fundamental analysis module provides a way to measure Icosavax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icosavax stock.
Icosavax |
Icosavax Company Current Ratio Analysis
Icosavax's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Icosavax Current Ratio | 20.89 X |
Most of Icosavax's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icosavax is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Icosavax has a Current Ratio of 20.89 times. This is much higher than that of the Biotechnology sector and 198.43% higher than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
Icosavax Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icosavax's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics of similar companies.Icosavax is currently under evaluation in current ratio category among its peers.
Icosavax Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | 547.9 M | |||
| Shares Outstanding | 50.23 M | |||
| Shares Owned By Insiders | 3.47 % | |||
| Shares Owned By Institutions | 87.64 % | |||
| Number Of Shares Shorted | 321.31 K | |||
| Price To Earning | 63.56 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 153.31 X | |||
| Gross Profit | (30.97 M) | |||
| EBITDA | (103.19 M) | |||
| Net Income | (96.71 M) | |||
| Cash And Equivalents | 242.8 M | |||
| Cash Per Share | 6.09 X | |||
| Total Debt | 8.79 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 20.89 X | |||
| Book Value Per Share | 4.64 X | |||
| Cash Flow From Operations | (71.48 M) | |||
| Short Ratio | 0.34 X | |||
| Earnings Per Share | (2.20) X | |||
| Target Price | 18.5 | |||
| Number Of Employees | 60 | |||
| Beta | 1.28 | |||
| Market Capitalization | 769.04 M | |||
| Total Asset | 238.68 M | |||
| Retained Earnings | (185.83 M) | |||
| Working Capital | 210.12 M | |||
| Z Score | 51.0 | |||
| Net Asset | 238.68 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world |